Vaidya Sane Ayurved Laboratories Limited
ListedSMEHealthcare / Pharmaceuticals · NSE
Madhavbaug is a medical service provider specializing in the treatment of chronic ailments such as cardiac diseases, diabetes, hypertension, obesity, and knee pain, using a combination of modern technology and traditional Ayurveda practices through non-invasive, multidisciplinary therapies. As of November 30, 2021, it operates 274 clinics across Maharashtra, Madhya Pradesh, Gujarat, Uttar Pradesh, Goa, Karnataka, Delhi, and Chhattisgarh, including 52 company-owned and 222 franchise clinics, along with two cardiac prevention and rehabilitation hospitals in Khopoli and Nagpur. The company also offers wellness products online through Madhavbaug Wellness and supports patients via the MIB Pulse App.
Price Band
₹73
Issue Size
₹20.23 Cr
Lot Size
1600 shares
GMP
—
Est. Listing
₹73
at current GMP
Subscribed
—
Open
10 Feb 2022
Close
15 Feb 2022
Allotment
21 Feb 2022
Refund
22 Feb 2022
Demat Credit
23 Feb 2022
Listing
23 Feb 2022
Last updated 12 days ago
Live Grey Market Premium
Vaidya Sane Ayurved Laboratories Limited GMP Today
Last updated: 19 Oct 2026
Current Premium
₹00.0%
Issue Price (Upper)
₹73
Band: ₹73
Estimated Listing Price
₹73
Upper price + GMP
Lot Size
1600 shares
Min investment ₹1,16,800
Estimated Profit / Lot
₹0
1600 × ₹0
Vaidya Sane Ayurved Laboratories Limited GMP Historical Trend
GMP History
Grey Market Premium trend
—
▲ 0 today
Updated over 1 year ago
Estimated Listing Price
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 8 Apr 2025 | — | 0.0% | ₹73 |
| 17 Dec 2025 | — | 0.0% | ₹73 |
GMP is unofficial market data. Not a guarantee of listing performance.
About Vaidya Sane Ayurved Laboratories Limited Public Issue & Market Profile
Vaidya Sane Ayurved Laboratories Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals sector with an aggregate issue size of ₹20.23 Crores. The shares are offered at a price band of ₹73 to ₹73 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
Public Issue & Pricing Context:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Basis of Allotment & Listing Timeline:
Following the close of bidding on 2022-02-15, the basis of allotment is scheduled to be finalized on 2022-02-21. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.
Frequently Asked Questions
What is Vaidya Sane Ayurved Laboratories Limited IPO GMP today?
The latest grey market premium for Vaidya Sane Ayurved Laboratories Limited IPO is ₹0, which indicates an expected listing price of ₹73.
What does Kostak Rate and Sauda mean in IPO GMP?
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
Is Grey Market Premium officially recognized?
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.